EssilorLuxottica announced in a press release its membership in the Collaborative Community of Ophthalmic Innovation (CCOI), a global group of patients, clinicians, researchers, regulators, and industry collaborating to accelerate breakthrough science into real-world solutions.

According to the company, the Group will contribute optical engineering excellence, digital health capabilities and global scale to help translate emerging science into meaningful patient outcomes.

In addition, the Group will engage in the CCOI’s key workstreams, including myopia, oculomics, artificial intelligence, age-related macular degeneration, and glaucoma, applying its scientific and technological strengths to advance global eye health, says EssilorLuxottica. OM